Masimo Corp (FRA:3M4)
€ 120.8 -0.9 (-0.74%) Market Cap: 6.52 Bil Enterprise Value: 7.27 Bil PE Ratio: 89.29 PB Ratio: 5.10 GF Score: 88/100

Masimo Corp at UBS Global Healthcare Conference Transcript

May 21, 2019 / 06:00PM GMT
Release Date Price: €124.16 (+0.66%)
Matthew Charles Taylor;Micah Young
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices;Masimo Corporation - Executive VP of Finance & CFO<

(technical difficulty)

Management from the Masimo team. We've got Micah Young, who's EVP and CFO of the company and joining in September -- October 2017, I think, okay? And prior to that, he was VP of Finance at NuVasive and worked at Zimmer in the distant past. And we also have here Eli Kammerman, VP of Business Development, Investor Relations, you can see her on my right, who's been with Masimo since July of 2009.

So Micah, I want to start off just to give you the opportunity to talk to investors about where Masimo is in its evolution. You just had your Investor Day last week, which is exciting. We were out there in California, unveiled a number of new product initiatives and you're making progress along a number of new vectors. So there's a lot to cover but maybe you could give us a little overview and then we'll dive a little bit deeper into some of those areas.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot